Pathophysiologically, pyoderma gangrenosum is an autoinflammatory neutrophilic dermatosis marked by innate immune dysregulation, neutrophil hyperactivation, and overexpression of cytokines such as TNF-α, IL-1β, IL-17, and IL-23 [8,9]. Here, IL1B is linked to pyoderma gangrenosum.